Literature DB >> 3923825

Heparin-like anticoagulant associated with plasma cell myeloma.

G S Chapman, C B George, D L Danley.   

Abstract

A 54-year-old man with plasma cell myeloma had sustained bleeding develop after prophylactic hip hemiarthroplasty. Routine coagulation studies revealed significant prolongation of the prothrombin time, activated partial thromboplastin time, and thrombin time. Further evaluation showed failure of the activated partial thromboplastin time to correct in a 1:1 mixture with pooled normal plasma, correction of the prolonged thrombin time by addition of protamine, and a normal reptilase time. A purified preparation of the immunoglobulin component of patient plasma produced the same pattern of coagulation abnormalities, suggesting the paraprotein possessed heparin-like anticoagulant activity. This appears to be a rare mechanism of bleeding diathesis in plasma cell myeloma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923825     DOI: 10.1093/ajcp/83.6.764

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.

Authors:  Irene Martínez-Martínez; José Ramón González-Porras; María José Cebeira; Felipe de Arriba; Salvador Espín; Nataliya Bohdan; Fernando José Corrales; Javier Corral; Vicente Vicente
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

2.  Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.

Authors:  Haorui Shen; Chao Wu; Lijuan Chen; Run Zhang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.